Cytogam
- Product NDC
- 49591-532
- 11-digit product format
- 495910532
- Labeler code
- 49591
- Product ID
- 49591-532_eaa03089-26d4-4945-b075-634cbf56dad2
- Type
- PLASMA DERIVATIVE
- Nonproprietary name
- HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
- Dosage form
- LIQUID
- Route
- INTRAVENOUS
- Labeler
- Kamada Ltd.
- Application
- BLA103189
- Marketing category
- BLA
- Marketing start
- 2023-06-01
- Substance
- HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
- Active strength
- 2500 mg/50mL
- Pharmacologic classes
- Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cytogam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 2500 mg/50mL |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 49591-532-50 | Cytogam | 50 mL in 1 VIAL, GLASS | LIQUID | 50 | | 1 |
| 49591-532-51 | Cytogam | 1 in 1 CARTON | LIQUID | 1 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 49591-532 | CYTOGAM (HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN) LIQUID [KAMADA LTD.] | 1 | Current NDC, 2 package rows | 20230602_c8e2bb3f-2a4d-4c55-b145-ba96c1928d44.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 49591-532-50 | 49591053250 | 50 mL in 1 VIAL, GLASS | 50 ml | | | | Historical |
| 49591-532-51 | 49591053251 | 1 VIAL, GLASS in 1 CARTON (49591-532-51) / 50 mL in 1 VIAL, GLASS (49591-532-50) | | 2023-06-01 | No | No | Historical |